<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25532568</article-id>
      <article-id pub-id-type="pmc">4307634</article-id>
      <article-id pub-id-type="publisher-id">3448</article-id>
      <article-id pub-id-type="doi">10.1186/1756-0500-7-940</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Adult-onset Still&#x2019;s disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mimura</surname>
            <given-names>Tetsuhiko</given-names>
          </name>
          <address>
            <email>tettim3@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Shimodaira</surname>
            <given-names>Masanori</given-names>
          </name>
          <address>
            <email>masanori19810813@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kibata</surname>
            <given-names>Minoru</given-names>
          </name>
          <address>
            <email>kibata@jichi.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsukadaira</surname>
            <given-names>Akihiro</given-names>
          </name>
          <address>
            <email>0375@imh.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shirahata</surname>
            <given-names>Kumiko</given-names>
          </name>
          <address>
            <email>k-shirahata@imh.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Iida Municipal Hospital, Nagano, Japan </aff>
        <aff id="Aff2"><label/>Department of Internal Medicine, Iida Municipal Hospital, 438 Yawata-machi, Iida, Nagano, 395-8502 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>940</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Mimura et al.; licensee BioMed Central. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Adult-onset Still&#x2019;s disease is a rare inflammatory condition of unknown origin characterized by high spiking fever, arthralgia, arthritis, myalgia, salmon-colored evanescent rash, and hepatosplenomegaly. The diagnosis of adult-onset Still&#x2019;s disease requires the exclusion of other possible disorders because it lacks specific clinical and histopathological findings. Adult-onset Still&#x2019;s disease rarely become fatal due to visceral involvements such as disseminated intravascular coagulation.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 22-year-old Chinese female presented to our medical center with high spiking fever for one week, myalgia for two weeks, and arthralgia and pink maculopapular rash for four weeks. She developed disseminated intravascular coagulation on the fourth day after admission. There was no other explanation for the fever and rash, including infection, malignancy, and collagenosis. Together, the high spiking fever, salmon-colored rash, splenomegaly, and excess hepatic enzyme, indicated adult-onset Still&#x2019;s disease based on the Yamaguchi criteria. Therefore, prednisolone therapy was initiated. The combination of nafamostat mesilate and prednisolone therapies caused a rapid reduction in the fever and rash. The inflammatory markers decreased immediately, and disseminated intravascular coagulation improved. Her symptoms resolved with low-dose prednisolone treatment, and she was monitored thereafter at our outpatient clinic.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>The previous use of nonsteroidal anti-inflammatory drugs could have caused disseminated intravascular coagulation in this patient with adult-onset Still&#x2019;s disease. We propose that physicians should consider the possibility of disseminated intravascular coagulation as a complication during the course of adult-onset Still&#x2019;s disease and suggest that prednisolone therapy should be initiated in the early stages of adult-onset Still&#x2019;s disease.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Still&#x2019;s disease</kwd>
        <kwd>Disseminated intravascular coagulation</kwd>
        <kwd>Hemophagocytic syndrome</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Adult-onset Still&#x2019;s disease (AOSD) is a systemic inflammatory disorder of unknown etiology characterized by high spiking fever, arthralgia, arthritis, myalgia, salmon-colored evanescent rash, and hepatosplenomegaly [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The diagnosis of AOSD requires the exclusion of other possible disorders because it lacks specific clinical and histopathological findings [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. During the course of AOSD, life-threatening conditions such as hepatic involvement, cardiac tamponade, respiratory distress syndrome, or pancytopenia caused by hemophagocytic syndrome (HS) occasionally develop [<xref ref-type="bibr" rid="CR5">5</xref>]. However, cases of AOSD with disseminated intravascular coagulation (DIC) are not common [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR10">10</xref>]. We report a case of AOSD with DIC, which was dramatically improved by prednisolone.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 22-year-old Chinese female presented to our medical center with a high spiking fever and a pink maculopapular rash on the trunk, face, and limb for one week (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>), myalgia for two weeks, and arthralgia for four weeks. Her fever was between 35&#xB0;C and 39&#xB0;C; its occurrence correlates with the appearance of the rash, and it was not relieved by treatment. She had been taking NSAID called loxoprofen for her fever for a few days, without improvement. The patient did not have allergies, a past medical history, alcoholism, herbal treatment, insect bites, or contact with any animal. She did not travel to any foreign country for the past two years.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Picture of the patient showing salmon-colored rash on her face and trunk.</bold>
</p></caption><graphic xlink:href="13104_2014_3448_Fig1_HTML" id="d30e317"/></fig></p>
      <p>Physical examination revealed high fever, a regular pulse of 100 beats per min, and normal blood pressure (116/84&#xA0;mmHg). There were no signs of anemia, jaundice, lymph node swelling, hepatosplenomegaly or goiter. Auscultation of the lungs revealed no rale, and her heart function sounded normal. Myalgia was detected in the arms and legs by pressure algometry.</p>
      <p>Blood sample analysis revealed high levels of C-reactive protein (3.03&#xA0;mg/dL; normal: 0&#x2013;0.3&#xA0;mg/dL), lactate dehydrogenase (751&#xA0;IU/L; normal: 109&#x2013;244&#xA0;IU/L), aspartate transaminase (76&#xA0;IU/L; normal: 10&#x2013;40&#xA0;IU/L), ferritin (1027&#xA0;ng/ml; normal: 10&#x2013;291&#xA0;ng/ml), and creatinine phosphokinase (239&#xA0;IU/L; normal: 40&#x2013;149&#xA0;IU/L). In contrast, the patient had normal white blood cell counts (6.4&#x2009;&#xD7;&#x2009;10<sup>3</sup>/&#x3BC;L; normal: 3.1-8.0&#x2009;&#xD7;&#x2009;10<sup>3</sup>/&#x3BC;L), hemoglobin (12.2&#xA0;g/dL; normal: 10.1-14.5&#xA0;g/dL), and platelet count (10.5&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L; normal: 11.0-34.0&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L), &#x3B3;-glutamyltransferase (18&#xA0;IU/L; normal: 8&#x2013;68&#xA0;IU/L), alanine transaminase (24&#xA0;IU/L; normal: 5&#x2013;44&#xA0;IU/L) and alkaline phosphatase (173&#xA0;IU/L; normal: 80&#x2013;260&#xA0;IU/L).</p>
      <p>Serology tests were negative for the rheumatoid factor, anti-nuclear antibodies, anti-DNA antibodies, anti-neutrophil cytoplasmic antibodies, and anti-Jo-1 antibodies. There was no marker of recent infection, including hepatitis B antigen, hepatitis C virus, HIV antibodies, Mycobacterium tuberculosis antigen, Epstein&#x2013;Barr virus, cytomegalovirus, herpes simplex viruses, mycoplasma pneumonia, Human parvovirus B19, Rickettsia japonica, or Orientia tsutsugamushi.</p>
      <p>Computed tomography (CT) images revealed splenomegaly, in the absence of abscess or tumor (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Echocardiography was negative for endocarditis.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Computed tomography images showing splenomegaly.</bold>
</p></caption><graphic xlink:href="13104_2014_3448_Fig2_HTML" id="d30e352"/></fig></p>
      <p>After admission, the high fever persisted, with increasing levels of hepatic and biliary enzymes (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). On day 4 after admission, the platelet count suddenly decreased to 6.3&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L, and the fibrinogen level decreased to 122&#xA0;mg/dL (normal: 190&#x2013;430&#xA0;mg/dL). In contrast, the patient had excess fibrin degradation product (FDP; 45.5&#xA0;&#x3BC;g/mL; normal: 1&#x2013;10&#xA0;&#x3BC;g/mL), and a high prothrombin time-international normalized ratio (PT-INR: 1.23; control: 1.0). Based on these data, she was diagnosed with DIC and nafamostat mesilate (200&#xA0;mg/day) therapy was initiated immediately.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Clinical course of a patient with adult-onset Still&#x2019;s disease.</bold> ALT, alanine transaminase; AST, aspartate transaminase; BT, body temperature; CRP, C-reactive protein; WBC, white blood cell count.</p></caption><graphic xlink:href="13104_2014_3448_Fig3_HTML" id="d30e372"/></fig></p>
      <p>A bone marrow biopsy showed hemophagocytosis, no blast cells, and no malformation (Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). Because the patient had fever, splenomegaly, and hypofibrinogenemia, but no evidence of malignancy, we diagnosed HS on the basis of these findings [<xref ref-type="bibr" rid="CR11">11</xref>].<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Bone marrow showing hemophagocytosis (black arrow).</bold>
</p></caption><graphic xlink:href="13104_2014_3448_Fig4_HTML" id="d30e392"/></fig></p>
      <p>There was no other explanation for the fever and rash, including infection, malignancy, and collagenosis. Together, the high spiking fever, salmon-colored rash, splenomegaly, and excess hepatic enzyme, indicated AOSD based on the Yamaguchi criteria [<xref ref-type="bibr" rid="CR9">9</xref>]. Therefore, prednisolone (30&#xA0;mg/day) therapy was initiated.</p>
      <p>The combination of nafamostat mesilate and prednisolone therapies caused immediate improvement of both the fever and rash. The inflammatory markers decreased immediately, and DIC improved. On day 34, the dosage of oral prednisolone was decreased from 30&#xA0;mg/day to 25&#xA0;mg/day, and the patient was discharged. Her symptoms resolved upon treatment with low-dose prednisolone, and she was monitored thereafter at our outpatient clinic.</p>
    </sec>
    <sec id="Sec3" sec-type="conclusions">
      <title>Conclusions</title>
      <p>The present case highlights the difficulty of diagnosing AOSD. Moreover, our case showed that AOSD could be a cause of DIC. The diagnosis of AOSD is clinically important and difficult because the disorder has no specific laboratory marker. The Yamaguchi criteria are widely recognized as the most sensitive tool to diagnose AOSD [<xref ref-type="bibr" rid="CR12">12</xref>]. Nonetheless, differential diagnosis is necessary to exclude other diseases, such as an infection (i.e., endocarditis), neoplastic diseases (i.e., lymphomas), or autoimmune diseases (i.e., vasculitis and polymyositis) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In this case, infection, neoplastic disease, or autoimmune disease was not revealed by an extensive examination that included blood test, CT scan, and bone marrow biopsy.</p>
      <p>In general, the treatment of AOSD involves corticosteroids, generally medium-high to high doses (0.5&#x2013;1&#xA0;mg/kg/day) of prednisone equivalent [<xref ref-type="bibr" rid="CR14">14</xref>]. For AOSD patients with severe visceral involvement, intravenous infusion of high-dose methylprednisolone generally provides efficient symptom relief. The corticosteroid response should be detected within a few hours or days [<xref ref-type="bibr" rid="CR14">14</xref>]. In our case, prednisolone therapy dramatically reduced the fever and rash within 3&#xA0;days.</p>
      <p>In patients with AOSD, macrophage hyperactivation and cytokine overproduction cause liver damage [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The onset of DIC is precipitated by a decrease in procoagulant factor caused by liver dysfunction [<xref ref-type="bibr" rid="CR16">16</xref>]. In some reports, the development of DIC in patients with AOSD was attributed to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. It is surmised that the disease-induced hepatic damage, further aggravated by aspirin, may be a significant factor in the initiation and perpetuation of intravascular coagulation [<xref ref-type="bibr" rid="CR17">17</xref>]. Accordingly, it is critical to monitor liver enzymes during the initial stage of AOSD therapy because NSAIDs may induce severe hepatitis [<xref ref-type="bibr" rid="CR3">3</xref>]. Another study suggests that high serum levels of unbound anti-inflammatory drugs, due to reduced serum albumin binding, may cause intravascular coagulation by their effect on prostaglandin synthesis [<xref ref-type="bibr" rid="CR18">18</xref>]. Because our patient was taking loxoprofen before her admission to our hospital, this NSAID may have triggered DIC.</p>
      <p>Bone marrow analysis revealed that our patient developed from HS. This condition is caused by hyperactivated T cells (Th1 cells) and macrophages, and the subsequent overproduction of cytokines such as IL-1, IL-6, and IFN-&#x3B3; [<xref ref-type="bibr" rid="CR19">19</xref>]. These cytokines contribute to the development of thrombotic reactions by activation of vascular endothelial cells and monocytes [<xref ref-type="bibr" rid="CR20">20</xref>]. Earlier cases of AOSD complicated with DIC and HS were treated successfully with NSAIDs, steroids, nafamostat mesilate, gabexate mesilate, or cyclosporine [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. To avoid the use of NSAIDS, our patient was treated with nafamostat mesilate and steroid therapy. She responded well to the treatment and was discharged on low-dose prednisolone.</p>
      <p>In conclusion, we report a case of AOSD complicated by HS and then DIC. The onset of DIC could be due to the use of NSAIDs. The differential diagnosis of AOSD requires several tests to rule out infections, neoplastic diseases, and autoimmune diseases. However, patients with AOSD may rapidly develop life-threatening conditions such as DIC. Therefore, we propose that physicians should be alert to the possibility of DIC as a complication during the course of AOSD and that prednisolone treatment should be initiated in the early stages of AOSD.</p>
    </sec>
    <sec id="Sec4">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>AOSD</term>
            <def>
              <p>Adult-onset Still&#x2019;s disease</p>
            </def>
          </def-item>
          <def-item>
            <term>DIC</term>
            <def>
              <p>Disseminated intravascular coagulation</p>
            </def>
          </def-item>
          <def-item>
            <term>CT</term>
            <def>
              <p>Computed tomography</p>
            </def>
          </def-item>
          <def-item>
            <term>HS</term>
            <def>
              <p>Hemophagocytic syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>FDP</term>
            <def>
              <p>Fibrin degradation product</p>
            </def>
          </def-item>
          <def-item>
            <term>PT-INR</term>
            <def>
              <p>Prothrombin time-international normalized ratio.</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interest.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>TM wrote the manuscript. MS was involved in the drafting, editing, correction and supervising of this paper. All authors diagnosed and treated the patient. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Dr. Kazuhiko Kaneda for helpful advise for diagnosis. The page charge of this paper is supported by Dr. Masahiro Mori, Department of Nephrology, Iida Municipal Hospital.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Castracane</surname>
              <given-names>VD</given-names>
            </name>
          </person-group>
          <article-title>The effect of reported prostaglandin synthetase inhibitors on estradiol-stimulated uterine prostaglandin biosynthesis in vivo in the ovariectomized rat</article-title>
          <source>Prostaglandins</source>
          <year>1976</year>
          <volume>12</volume>
          <fpage>1073</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="doi">10.1016/0090-6980(76)90140-4</pub-id>
          <pub-id pub-id-type="pmid">1005739</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaneoka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagayoshi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hiida</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adult Still&#x2019;s disease: review of 228 cases from the literature</article-title>
          <source>J Rheumatol</source>
          <year>1987</year>
          <volume>14</volume>
          <fpage>1139</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="pmid">3325642</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reginato</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>HR</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Ferreiros</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Adult onset Still&#x2019;s disease: experience in 23 patients and literature review with emphasis on organ failure</article-title>
          <source>Semin Arthritis Rheum</source>
          <year>1987</year>
          <volume>17</volume>
          <fpage>39</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="doi">10.1016/0049-0172(87)90015-1</pub-id>
          <pub-id pub-id-type="pmid">3306931</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Beard</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Casey</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Acute febrile juvenile rheumatoid arthritis in adults: cause of polyarthritis and fever</article-title>
          <source>South Med J</source>
          <year>1980</year>
          <volume>73</volume>
          <fpage>555</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="doi">10.1097/00007611-198005000-00005</pub-id>
          <pub-id pub-id-type="pmid">7375968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsunematsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasukawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Akizuki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adult Still&#x2019;s disease: a multicenter survey of Japanese patients</article-title>
          <source>J Rheumatol</source>
          <year>1990</year>
          <volume>17</volume>
          <fpage>1058</fpage>
          <lpage>1063</lpage>
          <pub-id pub-id-type="pmid">2213780</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokoyama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Suwa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shinozawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mimori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Akizuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ichikawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tojo</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A case of adult onset Still&#x2019;s disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation</article-title>
          <source>Nihon Rinsho Meneki Gakkai Kaishi</source>
          <year>1995</year>
          <volume>18</volume>
          <fpage>207</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="doi">10.2177/jsci.18.207</pub-id>
          <pub-id pub-id-type="pmid">7553055</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Jun</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>Adult-onset Still&#x2019;s disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A</article-title>
          <source>J Korean Med Sci</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>137</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.3346/jkms.2004.19.1.137</pub-id>
          <pub-id pub-id-type="pmid">14966357</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Govoni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trotta</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation</article-title>
          <source>Rheumatol Int</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>1355</fpage>
          <lpage>1357</lpage>
          <pub-id pub-id-type="doi">10.1007/s00296-008-0813-3</pub-id>
          <pub-id pub-id-type="pmid">19048255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vallianou</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Kouvidou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Naxaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aristodimou</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Acalculous cholecystitis with multiple organ failure and disseminated intravascular coagulation in a patient with adult onset Still&#x2019;s disease</article-title>
          <source>Ann Gastroenterol</source>
          <year>2014</year>
          <volume>27</volume>
          <fpage>289</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">24975054</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Namas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nannapaneni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Venkatram</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Altinok</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dhar</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>An unusual case of adult-onset still&#x2019;s disease with hemophagocytic syndrome. Necrotic leukoencephalopathy and disseminated intravascular coagulation</article-title>
          <source>Case Rep Rheumatol</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>128623</fpage>
          <pub-id pub-id-type="pmid">24707428</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henter</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Horne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Egeler</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ladisch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McClain</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winiarski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Janka</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>124</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="doi">10.1002/pbc.21039</pub-id>
          <pub-id pub-id-type="pmid">16937360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsunematsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasukawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Preliminary criteria for classification of adult Still&#x2019;s disease</article-title>
          <source>J Rheumatol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>424</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="pmid">1578458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Le Loet</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liote</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dubost</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Boissier</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Perroux-Goumy</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bregeon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Audran</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Comparative study of 6 types of criteria in adult Still&#x2019;s disease</article-title>
          <source>J Rheumatol</source>
          <year>1996</year>
          <volume>23</volume>
          <fpage>495</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="pmid">8832990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fautrel</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Adult-onset Still disease</article-title>
          <source>Best Pract Res Clin Rheumatol</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>773</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="doi">10.1016/j.berh.2008.08.006</pub-id>
          <pub-id pub-id-type="pmid">19028363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esdaile</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Tannenbaum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lough</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Hepatic abnormalities in adult onset Stills disease</article-title>
          <source>J Rheumatol</source>
          <year>1979</year>
          <volume>6</volume>
          <fpage>673</fpage>
          <lpage>679</lpage>
          <pub-id pub-id-type="pmid">529250</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Averbuch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pines</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kornovsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Levo</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis</article-title>
          <source>Ann Rheum Dis</source>
          <year>1992</year>
          <volume>51</volume>
          <fpage>347</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.51.3.347</pub-id>
          <pub-id pub-id-type="pmid">1575579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sbarbaro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Aspirin hepatotoxicity and disseminated intravascular coagulation</article-title>
          <source>Ann Intern Med</source>
          <year>1977</year>
          <volume>86</volume>
          <fpage>183</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.7326/0003-4819-86-2-183</pub-id>
          <pub-id pub-id-type="pmid">835940</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverman</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JJ</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shafai</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis</article-title>
          <source>J Pediatr</source>
          <year>1983</year>
          <volume>103</volume>
          <fpage>872</fpage>
          <lpage>876</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(83)80704-5</pub-id>
          <pub-id pub-id-type="pmid">6644421</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravelli</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Macrophage activation syndrome</article-title>
          <source>Curr Opin Rheumatol</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>548</fpage>
          <lpage>552</lpage>
          <pub-id pub-id-type="doi">10.1097/00002281-200209000-00012</pub-id>
          <pub-id pub-id-type="pmid">12192253</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlsen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Flatmark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prydz</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine</article-title>
          <source>Transplantation</source>
          <year>1988</year>
          <volume>46</volume>
          <fpage>575</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="doi">10.1097/00007890-198810000-00022</pub-id>
          <pub-id pub-id-type="pmid">3051564</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shinohara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hidaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohsuzu</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Calcinosis cutis and intestinal pseudoobstruction in a patient with adult onset Still&#x2019;s disease associated with recurrent relapses of disordered coagulopathy</article-title>
          <source>Intern Med</source>
          <year>1999</year>
          <volume>38</volume>
          <fpage>516</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.38.516</pub-id>
          <pub-id pub-id-type="pmid">10411361</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
